Quarterly report pursuant to Section 13 or 15(d)

Schedule of Accrued Expenses (Details) (Parenthetical)

v3.22.2.2
Schedule of Accrued Expenses (Details) (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
BioNTech Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Deferred liability $ 1,375  
Genentech Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Deferred revenue 33 $ 33
CFF Agreement [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Deferred liability $ 194 $ 899